Will the First Approved Automated Insulin Delivery System Be a Game-Changer in Type 1 Diabetes Management?

Por Castle, Jessica R.
Publicado no Diabetes Technol Ther (2017)

Advances in Subcutaneous Glucose Sensing

Por Castle, Jessica R.
Publicado no Diabetes Technol Ther (2017)

Where Do We Stand with Closed-Loop Systems and Their Challenges?

Por Jackson, Melanie, Castle, Jessica R.
Publicado no Diabetes Technol Ther (2020)

Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy

Por Castle, Jessica R., Kenneth Ward, W.
Publicado em 2010

Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions

Por Castle, Jessica R., Jacobs, Peter G.
Publicado no J Diabetes Sci Technol (2016)

Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue

Por Wilson, Leah M., Castle, Jessica R.
Publicado no J Diabetes Sci Technol (2018)

Recent Advances in Insulin Therapy

Por Wilson, Leah M., Castle, Jessica R.
Publicado no Diabetes Technol Ther (2020)

How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future

Por Castle, Jessica R., Rocha, Lolis, Ahmann, Andrew
Publicado no J Diabetes Sci Technol (2020)

Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia

Por Ward, W Kenneth, Castle, Jessica R, Youssef, Joseph El
Publicado em 2011

Future of Automated Insulin Delivery Systems

Por Castle, Jessica R., DeVries, J. Hans, Kovatchev, Boris
Publicado no Diabetes Technol Ther (2017)

Role of glucagon in automated insulin delivery

Por Wilson, Leah M., Jacobs, Peter G., Castle, Jessica R.
Publicado no Endocrinol Metab Clin North Am (2019)

Can Glucose Be Monitored Accurately at the Site of Subcutaneous Insulin Delivery?

Por Ward, W. Kenneth, Castle, Jessica R., Jacobs, Peter G., Cargill, Robert S.
Publicado no J Diabetes Sci Technol (2014)

Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure

Por Huang, Enoch, Demirel, Shaban, Bliss, Chanelle, Savaser, Davut, Castle, Jessica R.
Publicado no Diabetes Technol Ther (2020)

Continuous Glucose Monitoring in Subjects with Type 1 Diabetes: Improvement in Accuracy by Correcting for Background Current

Por Youssef, Joseph El, Castle, Jessica R., Engle, Julia M., Massoud, Ryan G., Ward, W. Kenneth
Publicado em 2010

Factors Influencing the Effectiveness of Glucagon for Preventing Hypoglycemia

Por Castle, Jessica R, Engle, Julia M, El Youssef, Joseph, Massoud, Ryan G, Ward, W Kenneth
Publicado em 2010

Discomfort from an Alkaline Formulation Delivered Subcutaneously in Humans: Albumin at pH 7 versus pH 10

Por Ward, W. Kenneth, Castle, Jessica R., Branigan, Deborah L., Massoud, Ryan G., Youssef, Joseph El
Publicado em 2012

A Review of Artificial Pancreas Technologies with an Emphasis on Bi-hormonal Therapy

Por Bakhtiani, Parkash A., Zhao, Lauren M., Youssef, Joseph El, Castle, Jessica R., Ward, W. Kenneth
Publicado em 2013

Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs

Por Resalat, Navid, Hilts, Wade, Youssef, Joseph El, Tyler, Nichole, Castle, Jessica R., Jacobs, Peter G.
Publicado no J Diabetes Sci Technol (2019)

Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas

Por Jackson, Melanie A., Caputo, Nicholas, Castle, Jessica R., David, Larry L., Roberts, Charles T., Ward, W. Kenneth
Publicado em 2012

Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes

Por Reddy, Ravi, Resalat, Navid, Wilson, Leah M., Castle, Jessica R., El Youssef, Joseph, Jacobs, Peter G.
Publicado no J Diabetes Sci Technol (2019)